Fennec Pharmaceuticals Inc. (RV41)
Market Closed
17 Jul, 20:00
€
9. 15
+0.05
+0.5495%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.23 Eps
€ 9.1
Previous Close Want to track RV41 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.04 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RV41 Earnings Reports FAQ
What is the earnings per share (EPS) for RV41?
The current EPS is 0.23.
What is the company's earnings growth rate?
Fennec Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Fennec Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Fennec Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RV41 at this time, as Fennec Pharmaceuticals Inc has no recent EPS data to calculate it.
